Ketamine may reduce pain for some people with severe, treatment-resistant migraines, particularly when established treatments have not provided enough relief.
However, the research remains limited, and results depend on the type of migraine, the method of administration, and the treatment protocol.
The most encouraging findings involve people with refractory chronic migraine who received prolonged ketamine infusions in closely monitored settings.
A single low-dose treatment for an acute migraine has not shown the same level of benefit.
This article explains what current research says about ketamine for migraines, who may be considered for treatment, possible side effects, and what patients can realistically expect.
Does Ketamine Help Migraines?
Ketamine may help some people with chronic, difficult-to-treat migraines, but it is not considered a standard first-line migraine treatment.
Small observational studies have found that prolonged ketamine infusions can reduce short-term pain in certain patients with refractory chronic migraine.
However, the results have varied, and researchers have not established a universal migraine treatment protocol or determined how long improvement typically lasts.
Evidence is less encouraging when ketamine is administered as a single low-dose treatment for an acute migraine.
In one randomized emergency department study, low-dose intravenous ketamine did not provide a clinically meaningful improvement in migraine pain compared with placebo.
Participants receiving ketamine also reported more fatigue and generalized discomfort.
A 2023 systematic review reached a similar conclusion.
Studies show short ketamine boluses did not consistently reduce migraine intensity, while longer infusions produced more encouraging findings in observational studies.
The reviewers noted that the overall quality of evidence remained low.
The clearest takeaway is that ketamine may be considered for carefully selected people with severe, treatment-resistant migraine.
It should not be viewed as a guaranteed way to stop a typical migraine attack.
What Is a Refractory or Intractable Migraine?
Refractory or intractable migraine generally refers to migraine that continues to cause substantial symptoms and disability despite appropriate treatment attempts.
Someone with refractory migraine may have tried several acute and preventive therapies without receiving enough relief.
They may experience frequent headache days, prolonged attacks, medication side effects, or repeated disruptions to work, sleep, relationships, and daily activities.
Most ketamine migraine studies involve people with chronic migraine.
Chronic migraine is generally defined as having headaches on at least 15 days per month for more than three months, with migraine features on at least eight of those days.
Ketamine has also been studied in connection with:
- Status migrainosus, which is a severe migraine attack that continues for an extended period
- Chronic daily headache
- New daily persistent headache
- Migraine with prolonged aura
- Headaches that have not responded to several conventional treatments
These conditions are not interchangeable.
A treatment that shows potential for hospitalized patients with severe chronic migraine may not produce the same results for someone with occasional episodic migraine.
How Does Ketamine Work for Migraines?
Ketamine affects several brain pathways involved in pain perception.
One of its primary actions is blocking N-methyl-D-aspartate receptors, commonly called NMDA receptors.
NMDA receptors respond to glutamate, an important chemical messenger involved in communication between nerve cells.
Excessive or poorly regulated glutamate activity may contribute to increased pain sensitivity and the continued activation of migraine-related pain pathways.
Ketamine also interacts with other receptors and may influence inflammation, mood, perception, and how the nervous system processes pain.
Its effects are more complex than simply blocking one chemical or “resetting” the brain.
Ketamine and Central Sensitization
Central sensitization occurs when the nervous system becomes unusually responsive to pain and sensory signals.
As migraines become more frequent or persistent, the brain and spinal cord may react more strongly to input that would not normally be painful.
Light, sound, movement, smells, touch, and routine activity may become increasingly uncomfortable.
Researchers believe ketamine’s effects on NMDA receptors may help interrupt parts of this amplified pain response.
This is one reason ketamine has been studied more often for persistent, difficult-to-treat pain than for occasional mild headaches.
However, reduced central sensitization remains a proposed mechanism.
Researchers have not established that ketamine reliably reverses this process in every person with migraine.
Ketamine and Migraine Aura
Migraine aura may include temporary visual, sensory, speech, or other neurological symptoms that commonly develop before or during a migraine.
Aura is associated with a wave of changing electrical activity across the brain called cortical spreading depolarization.
Because glutamate and NMDA receptors are involved in this process, researchers have investigated whether ketamine can reduce aura symptoms.
One small randomized trial found that intranasal ketamine reduced the severity of prolonged migraine aura, although it did not significantly shorten its duration.
Larger studies are needed before these findings can be applied broadly to people who experience migraine with aura.
What Does the Research Say About Ketamine for Migraines?
Research on ketamine for migraines includes small clinical trials, case series, retrospective studies, observational studies, and systematic reviews.
Treatment methods and patient populations vary considerably, making direct comparisons difficult.
| Research area | What studies found | Main limitation |
|---|---|---|
| Single low-dose treatment for acute migraine | Did not consistently provide greater pain relief than placebo or established emergency treatments | Small studies, short follow-up periods, and different doses |
| Multi-day treatment for refractory chronic migraine | Some patients experienced meaningful short-term pain reduction | Most studies were observational and lacked placebo groups |
| Intranasal ketamine for prolonged migraine aura | May reduce aura severity in certain patients | Very small study population |
| Intranasal ketamine as rescue treatment | Some patients reported lower headache intensity and improved quality of life | Descriptive data without a control group |
| Long-term migraine improvement | Some patients reported benefits after treatment ended | Duration varied, and controlled long-term research remains limited |
Research on Prolonged IV Ketamine Infusions
A small 2016 case series followed six patients with refractory chronic migraine who received intravenous ketamine in a hospital.
All six reached the study’s target level of short-term pain reduction.
However, the study did not include a control group and was too small to show how often similar results would occur in a larger population.
A later observational pilot study also found that ketamine had the potential to reduce short-term pain in people with refractory chronic migraine.
The researchers emphasized the need for larger controlled trials.
In a 2022 retrospective study involving inpatient treatment for headache disorders, ketamine was associated with at least a 50% reduction in pain for 34.4% of migraine patients.
Treatment lasted an average of approximately five days, and side effects were recorded during 42.4% of ketamine infusions.
These findings do not mean that approximately one-third of everyone receiving outpatient ketamine treatment will experience the same outcome.
The study involved patients with persistent, difficult-to-treat headaches who received prolonged treatment in a hospital setting.
Research on Ketamine for Acute Migraine Attacks
Research involving a single ketamine treatment for acute migraine has generally been less positive.
In one randomized emergency department trial, a low-dose IV ketamine bolus did not provide clinically meaningful pain relief compared with placebo.
Other reviews have found that ketamine performed less favorably than certain established emergency migraine treatments in some trials.
An American Headache Society evidence update also concluded that more evidence is needed before ketamine can be recommended as a standard injectable treatment for acute migraine in emergency departments.
What Types of Ketamine Have Been Studied for Migraines?
Ketamine can be administered in several ways, but the level of research is not the same for every method.
IV Ketamine Infusions
Intravenous administration allows clinicians to control how quickly ketamine enters the bloodstream and adjust treatment based on the patient’s response.
Most of the encouraging migraine findings have involved prolonged IV infusions delivered over several days in an inpatient or closely monitored setting.
These protocols differ substantially from the shorter outpatient protocols commonly used for mental health conditions.
There is no universally accepted IV ketamine protocol for migraines.
Treatment length, infusion rate, monitoring requirements, and follow-up practices vary among medical centers and research studies.
Intranasal Ketamine
Intranasal ketamine has been studied for prolonged migraine aura and as a rescue treatment for refractory chronic migraine.
A 2023 descriptive study found that patients using intranasal ketamine reported reduced headache intensity and improved quality of life.
Many participants continued using it despite experiencing side effects.
The researchers noted that careful patient selection and safety precautions are important because of the potential for frequent or excessive use.
These results do not establish intranasal ketamine as a routine migraine treatment.
Intranasal and IV protocols also should not be treated as interchangeable.
Other Routes of Administration
Ketamine has also been explored through subcutaneous and other routes, but the available evidence is limited.
Differences in absorption, treatment duration, dosing, and clinical setting can substantially affect the patient experience and possible results.
Ketamine should only be used through a treatment plan prescribed and monitored by a qualified medical professional.
Who Might Be Considered for Ketamine Migraine Treatment?
Ketamine may be discussed when migraine symptoms remain severe despite appropriate care.
A possible candidate might:
- Have chronic, refractory, or otherwise difficult-to-treat migraines
- Experience frequent or prolonged attacks
- Have tried multiple acute and preventive treatments
- Continue to experience substantial pain or disability
- Be able to receive treatment in a properly monitored setting
- Understand that improvement is not guaranteed
- Continue working with a neurologist or headache specialist when appropriate
Ketamine is not usually the first treatment considered for someone recently diagnosed with migraine.
Established acute and preventive treatments have stronger evidence and more standardized guidelines.
A complete evaluation should review the person’s diagnosis, migraine pattern, previous treatments, current medications, physical health, mental health history, and treatment goals.
Who May Not Be a Good Candidate?
Certain medical or personal factors may make ketamine treatment inappropriate or require additional precautions.
These may include:
- Poorly controlled high blood pressure
- Certain heart or blood vessel conditions
- A history of psychosis or severe uncontrolled psychiatric symptoms
- Current problems involving substance misuse
- Significant liver disease
- Urinary or bladder problems
- Pregnancy or breastfeeding
- Medications that could interact with ketamine
- A previous serious reaction to treatment
This is not a complete list.
A qualified medical professional must evaluate each person individually.
Because ketamine can affect blood pressure, heart rate, perception, awareness, and coordination, appropriate screening and monitoring are important even when lower, subanesthetic amounts are used.
Ketamine Infusion for Migraines: What to Expect
The exact experience depends on the treatment setting, route of administration, treatment length, and reason ketamine is being considered.
Initial Consultation
The provider may review:
- How often migraines occur
- How long attacks usually last
- Whether aura is present
- Known migraine triggers
- Current and previous treatments
- Medication side effects
- Other medical or mental health conditions
- How migraines affect daily life
Bring an updated medication list and a summary of previous migraine treatments.
A headache diary can also help show patterns in migraine frequency, intensity, duration, and possible triggers.
Pre-Treatment Screening
Before treatment, the clinical team may check blood pressure, heart rate, medical history, medications, and other health factors.
Depending on the proposed protocol and the patient’s health history, additional testing may be appropriate.
Longer or repeated treatments may require closer attention to liver function, urinary health, and other potential risks.
Monitoring During Treatment
During an IV infusion, clinicians may monitor:
- Blood pressure
- Heart rate
- Oxygen levels
- Breathing
- Comfort
- Awareness
- Psychological response
The amount of monitoring required depends on the treatment dose, infusion length, clinical setting, medical history, and provider protocol.
Sensations During Treatment
Temporary sensations may include:
- Feeling detached from the body or surroundings
- Changes in the perception of time or space
- Dizziness or lightheadedness
- Blurry vision
- Vivid thoughts or dreamlike experiences
- Nausea
- Anxiety
- Sleepiness
- Changes in blood pressure or heart rate
Some people find the experience calming, while others may feel uncomfortable or disoriented.
The clinical team should remain available throughout treatment to monitor symptoms and provide support.
Recovery After Treatment
Patients generally need time to recover before leaving the treatment facility.
Driving, operating machinery, making important decisions, or immediately returning to demanding activities may not be appropriate.
Arrange transportation according to the provider’s instructions.
Follow all post-treatment directions and report symptoms that are severe, persistent, or unexpected.
How Fast Does Ketamine Work for Migraines?
Ketamine does not follow one predictable migraine relief timeline.
Some people in prolonged-infusion studies experienced improvement during treatment or by the end of a multi-day hospital stay.
These findings do not mean that every patient will feel relief during the first hour or after one outpatient session.
Response may be affected by:
- Migraine type
- Frequency and duration of attacks
- Previous treatment history
- Route of administration
- Infusion length
- Other pain conditions
- Mental health conditions
- Individual biological differences
A lack of immediate improvement does not always mean that treatment has failed.
However, continuing treatment without measurable benefit should be discussed with the prescribing provider.
How Long Can Ketamine Migraine Relief Last?
There is no standard duration of migraine relief after ketamine treatment.
Some patients in observational studies experienced only short-term improvement.
Others reported benefits that continued after treatment ended.
Controlled research has not established a reliable average duration or a standard maintenance schedule.
A 2023 systematic review found that follow-up periods ranged from several hours in randomized trials to as long as 18 months in some observational studies.
Differences in study design and evidence quality make it difficult to predict how long an individual response may last.
Patients and clinicians may track:
- Number of headache days
- Number of migraine days
- Average pain intensity
- Duration of attacks
- Use of rescue medication
- Ability to work, sleep, exercise, and complete daily activities
Tracking these outcomes provides a more useful measure of progress than judging treatment by one especially good or bad day.
Potential Benefits of Ketamine for Migraines
Limited studies have reported several possible benefits for selected patients, including:
- Reduced migraine intensity
- Short-term relief from prolonged or persistent pain
- Fewer severe headache days in some patients
- Improved daily functioning
- Better quality of life
- Possible improvement in coexisting mood symptoms
Researchers have also proposed that ketamine may affect central sensitization and abnormal pain signaling.
These mechanisms are still being studied and should not be presented as guaranteed treatment outcomes.
Some patients experience meaningful improvement, some notice a modest change, and others receive no benefit.
Ketamine should not be described as a migraine cure.
It may provide temporary symptom relief for certain patients, but it does not remove every biological, environmental, or neurological factor involved in migraine.
Ketamine for Migraines: Side Effects and Risks
Ketamine can cause side effects even when administered below anesthetic levels.
Possible short-term effects include:
- Dissociation or detachment
- Dizziness
- Nausea or vomiting
- Blurry vision
- Fatigue or sedation
- Anxiety
- Hallucinations
- Vivid dreams or nightmares
- Changes in blood pressure
- Increased heart rate
- Temporary confusion
- Difficulty with coordination
Repeated or prolonged exposure may raise additional concerns involving:
- Liver function
- Bladder and urinary health
- Memory or cognition
- Tolerance
- Misuse or dependence
The likelihood of side effects depends on the treatment amount, duration, frequency, other medications, and the patient’s medical history.
Receiving ketamine in a supervised clinical setting allows the medical team to monitor changes and respond when side effects occur.
Ketamine vs. Standard Migraine Treatments
Ketamine is generally considered a specialized option rather than a replacement for established migraine care.
Acute migraine treatments may include:
- Nonsteroidal anti-inflammatory medications
- Triptans
- Gepants
- Ditans
- Anti-nausea medications
- Dihydroergotamine
- Neuromodulation devices
Preventive treatments may include:
- CGRP-targeting therapies
- OnabotulinumtoxinA for appropriate chronic migraine patients
- Certain blood pressure medications
- Certain antiseizure medications
- Certain antidepressants
- Gepants used preventively
- Lifestyle and trigger management
Ketamine is more often explored when standard treatments have not provided enough relief, have caused unacceptable side effects, or are not appropriate for the patient.
A comprehensive care plan may also address sleep, hydration, stress, nutrition, hormonal changes, medication overuse, neck pain, and other factors that can influence migraine frequency.
Considering Ketamine Therapy in Arizona
Research on ketamine for migraines is promising in specific situations, but many questions remain unanswered.
The strongest findings involve people with severe, refractory chronic migraine receiving longer treatments under close medical supervision.
AZ Wellness Center provides professionally supervised ketamine therapy in Arizona within a supportive clinical environment.
Its ketamine services currently focus on mental wellness concerns, including depression, anxiety, and other treatment-resistant mental health conditions.
People who experience migraines should discuss their complete health history during a consultation.
A provider can review current medications, previous treatment responses, health risks, and whether coordination with a neurologist or headache specialist is appropriate.
Ketamine should be considered as one possible part of a broader care plan, not as a guaranteed cure or a substitute for a complete migraine evaluation.
FAQs: Ketamine for Migraines
Does ketamine stop a migraine?
Ketamine does not reliably stop every migraine. Single low-dose IV treatments have not consistently outperformed placebo or established emergency treatments. Longer infusions have shown more encouraging short-term results in some patients with refractory chronic migraine.
How fast does ketamine work for migraines?
Some patients in multi-day infusion studies experienced improvement during treatment or by the end of the infusion period. These findings do not prove that one short ketamine session will provide immediate migraine relief.
How long does ketamine migraine relief last?
Relief may last hours, days, weeks, or longer, but some people receive no sustained benefit. Researchers have not established a predictable duration of relief or a standard maintenance schedule.
What are the side effects of ketamine for migraines?
Possible side effects include dissociation, dizziness, nausea, fatigue, anxiety, vivid dreams, hallucinations, blurry vision, increased blood pressure, and changes in heart rate. Repeated treatment may also raise concerns involving the liver, urinary system, tolerance, and misuse.
Can ketamine be used with other migraine medications?
Ketamine may interact with medications or affect how a treatment plan is managed. Patients should provide a complete medication list and should not stop, combine, or change migraine medications without guidance from the prescribing clinician.
